Shao Mu Guo
Director/Board Member at YIDA CHINA HOLDINGS LIMITED
Shao Mu Guo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| YIDA CHINA HOLDINGS LIMITED | Director/Board Member | 2014-05-31 | - |
| Independent Dir/Board Member | 2014-05-31 | - | |
| GALAXYCORE INC. | Director/Board Member | 2014-01-22 | - |
| Independent Dir/Board Member | 2014-01-22 | - | |
| FANTASIA HOLDINGS GROUP CO., LIMITED | Director/Board Member | 2015-01-31 | - |
| Independent Dir/Board Member | 2015-01-31 | - | |
| SUNKWAN PROPERTIES GROUP LIMITED | Director/Board Member | 2020-10-26 | - |
| Independent Dir/Board Member | 2020-10-26 | - | |
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Director/Board Member | 2020-11-22 | - |
| Independent Dir/Board Member | 2020-11-22 | - | |
MicuRx Pharmaceuticals, Inc.
 MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Director/Board Member | 2017-12-31 | - |
| Independent Dir/Board Member | 2017-12-31 | - | |
Shanghai Xinwei Medical Technology Co., Ltd.
 Shanghai Xinwei Medical Technology Co., Ltd. BiotechnologyHealth Technology Shanghai Xinwei Medical Technology Co., Ltd. develops products for the prevention and treatment of stroke. The company is based in Shanghai, China. The Chinese company was founded in 2016 by Guo Hui Wang, who has been the CEO since 2016. | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - |
Career history of Shao Mu Guo
Former positions of Shao Mu Guo
| Companies | Position | Start | End |
|---|---|---|---|
| GANGLONG CHINA PROPERTY GROUP LIMITED | Director/Board Member | 2020-05-31 | 2023-11-30 |
| Independent Dir/Board Member | 2020-05-31 | 2023-11-30 | |
Morgan Stanley Asia Ltd.
 Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Corporate Officer/Principal | 2007-03-31 | 2013-03-31 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Shao Mu Guo
| Zhejiang University | Undergraduate Degree |
| University of Southern California | Graduate Degree |
| Yale School of Management | Masters Business Admin |
Statistics
International
| China | 11 |
| Hong Kong | 7 |
| United States | 4 |
Operational
| Director/Board Member | 10 |
| Independent Dir/Board Member | 8 |
| Corporate Officer/Principal | 6 |
Sectoral
| Finance | 8 |
| Consumer Services | 4 |
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| YIDA CHINA HOLDINGS LIMITED | Finance |
| GALAXYCORE INC. | Electronic Technology |
| FANTASIA HOLDINGS GROUP CO., LIMITED | Finance |
| GANGLONG CHINA PROPERTY GROUP LIMITED | Finance |
| SUNKWAN PROPERTIES GROUP LIMITED | Finance |
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
| Private companies | 10 |
|---|---|
| Citigroup Global Markets China Ltd. | |
| Salomon Smith Barney, Inc. | Finance |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |
| HSBC Markets Asia Ltd. | |
Morgan Stanley Asia Ltd.
Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Finance |
| Ljmjl Advisors Hk Ltd. | |
| Mjl Fun Ltd. | |
| HSBC Investment Asia Holdings Ltd. | |
JPMorgan Chase Bank (China) Co. Ltd.
 JPMorgan Chase Bank (China) Co. Ltd. Regional BanksFinance Part of JPMorgan Chase & Co., JPMorgan Chase Bank (China) Co. Ltd. is a Chinese company that offers trade finance, cash management, and commercial banking. The company is based in Beijing, China. | Finance |
Shanghai Xinwei Medical Technology Co., Ltd.
Shanghai Xinwei Medical Technology Co., Ltd. BiotechnologyHealth Technology Shanghai Xinwei Medical Technology Co., Ltd. develops products for the prevention and treatment of stroke. The company is based in Shanghai, China. The Chinese company was founded in 2016 by Guo Hui Wang, who has been the CEO since 2016. | Health Technology |
- Stock Market
- Insiders
- Shao Mu Guo
- Experience
